88449114 - ICHNOS SCIENCES

Information

• Trademark
• 88449114

• Source

• Serial Number

  88449114

• International Classifications

  • 3 - Bleaching preparations and other substances for laundry use
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services
  • 45 - Legal services

• Filing Date

  May 28, 2019
  5 years ago

• Transaction Date

  February 05, 2024
  a year ago

• Status Date

  May 29, 2023
  a year ago

• Published for Opposition Date

  March 03, 2020
  5 years ago

• Location Date

  September 21, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  GORAN, BRADLEY TAYLOR

• Attorney Docket Number

  5305.0010000

  Attorney Name

  Monica Riva Talley

  Law Office Assigned Location Code

  L70

• Owners

  • Glenmark Pharmaceuticals Limited

Case File Statements

• GS0411: Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; Publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical disease, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine
• GS0051: Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic obstructive pulmonary disease (COPD); Opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays
• GS0031: Cosmetic soaps; Skin soaps; shampoos; sunscreen for cosmetic use; perfumery; essential oils; body powder; cosmetics; anti-aging creams; hair lotion; cosmetic skin care preparations; skin creams; skin moisturizing gel; face wash; moisturizing body lotions; and non-medicated mouthwashes
• GS0351: Campaign for patient support program, namely, promoting public awareness for patients with cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases
• GS0451: Licensing of patents, trademarks and intellectual property
• GS0441: Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management. dermatology, diabetology, respiratory diseases and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases
• GS0101: Medical apparatus and instruments, namely, spirometers; medical devices, namely, inhalers sold empty, nebulizers; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus
• D10000: "SCIENCES"
• GS0421: Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases, biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; pharmaceutical research and development; research and development for new products for others; chemical, pharmaceutical, nutraceuticals and nutritional science, dermo-cosmetic and biotechnology analysis and research; design and testing for new product development; Diagnostic product testing and analysis, namely, medical research and product research for industrial uses; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes including and not limited to bacteriological research services, biomedical research services, laboratory research services, clinical trial services, pharmacological research services, medical research laboratory services, scientific and technological services and research and design relating thereto

Case File Event Statements

• 5/30/2023 - a year ago

  56 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 5/29/2023 - a year ago

  55 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 9/22/2022 - 2 years ago

  54 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 9/21/2022 - 2 years ago

  53 - SOU EXTENSION 5 GRANTED Type: EX5G

• 9/8/2022 - 2 years ago

  52 - SOU EXTENSION 5 FILED Type: EXT5

• 9/21/2022 - 2 years ago

  51 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 9/8/2022 - 2 years ago

  50 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 4/16/2022 - 3 years ago

  49 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/14/2022 - 3 years ago

  48 - SOU EXTENSION 4 GRANTED Type: EX4G

• 4/14/2022 - 3 years ago

  47 - SOU EXTENSION 4 FILED Type: EXT4

• 4/14/2022 - 3 years ago

  46 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/28/2021 - 3 years ago

  45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/26/2021 - 3 years ago

  44 - SOU EXTENSION 3 GRANTED Type: EX3G

• 10/26/2021 - 3 years ago

  43 - SOU EXTENSION 3 FILED Type: EXT3

• 10/26/2021 - 3 years ago

  42 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 9/7/2021 - 3 years ago

  41 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/7/2021 - 3 years ago

  40 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 9/7/2021 - 3 years ago

  39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 9/7/2021 - 3 years ago

  38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/29/2021 - 3 years ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/27/2021 - 3 years ago

  36 - SOU EXTENSION 2 GRANTED Type: EX2G

• 4/27/2021 - 3 years ago

  35 - SOU EXTENSION 2 FILED Type: EXT2

• 4/27/2021 - 3 years ago

  34 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 4/14/2021 - 4 years ago

  33 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 10/28/2020 - 4 years ago

  32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/26/2020 - 4 years ago

  31 - SOU EXTENSION 1 GRANTED Type: EX1G

• 10/26/2020 - 4 years ago

  30 - SOU EXTENSION 1 FILED Type: EXT1

• 10/26/2020 - 4 years ago

  29 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 4/28/2020 - 4 years ago

  28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 3/3/2020 - 5 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/3/2020 - 5 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/12/2020 - 5 years ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/27/2020 - 5 years ago

  24 - ASSIGNED TO LIE Type: ALIE

• 1/24/2020 - 5 years ago

  23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/24/2020 - 5 years ago

  22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/24/2020 - 5 years ago

  21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/24/2020 - 5 years ago

  20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/24/2020 - 5 years ago

  19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/14/2020 - 5 years ago

  18 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 10/8/2019 - 5 years ago

  17 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 9/19/2019 - 5 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/19/2019 - 5 years ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/19/2019 - 5 years ago

  14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/19/2019 - 5 years ago

  13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/19/2019 - 5 years ago

  12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/17/2019 - 5 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/16/2019 - 5 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/16/2019 - 5 years ago

  9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/7/2019 - 5 years ago

  8 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Type: CEPE

• 9/7/2019 - 5 years ago

  7 - ASSIGNED TO LIE Type: ALIE

• 9/6/2019 - 5 years ago

  6 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN

• 9/6/2019 - 5 years ago

  5 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP

• 9/6/2019 - 5 years ago

  4 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA

• 8/16/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 6/12/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/31/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP